Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

In the media

Piperacillin-tazobactam shortage 'serious', says RPS spokesperson

2 July 2017: Philip Howard, Royal Pharmaceutical Society (RPS) spokesman on antimicrobial resistance, gave a comment to The Observer about the shortage of piperacillin-tazobactam, a combination antibiotic widely used in hospitals. “This is one of the more serious shortages we’ve had to face,” Howard said, although he added that there were enough supplies of other drugs for patients to get the treatment they needed. He also warned that “we need to ensure that we use a broader range of antibiotics in our hospitals, so that if there is a global supply problem, it doesn’t have such a large impact.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20203131

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.